172 related articles for article (PubMed ID: 22724421)
1. Editorial: Paving the way for improved antiplatelet therapy.
Grove EL
Curr Pharm Des; 2012; 18(33):5195-6. PubMed ID: 22724421
[No Abstract] [Full Text] [Related]
2. Clinical use of clopidogrel.
Sarafoff N; Byrne RA; Sibbing D
Curr Pharm Des; 2012; 18(33):5224-39. PubMed ID: 22724411
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet medications: old and emerging therapies.
Stone WM; Naidu SG; Chapital A; Money SR
Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
[TBL] [Abstract][Full Text] [Related]
4. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
Price MJ
Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
[No Abstract] [Full Text] [Related]
5. The evolution of antiplatelet therapy in cardiovascular disease.
Yousuf O; Bhatt DL
Nat Rev Cardiol; 2011 Jul; 8(10):547-59. PubMed ID: 21750497
[TBL] [Abstract][Full Text] [Related]
6. Platelet Signaling Pathways and New Inhibitors.
Grover SP; Bergmeier W; Mackman N
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of P2Y12 inhibitors according to diabetes, age, gender, body mass index and body weight: systematic review and meta-analyses of randomized clinical trials.
Zaccardi F; Pitocco D; Willeit P; Laukkanen JA
Atherosclerosis; 2015 Jun; 240(2):439-45. PubMed ID: 25897998
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet drugs: which targets for which treatments?
Gachet C
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S313-22. PubMed ID: 26149041
[TBL] [Abstract][Full Text] [Related]
9. New anti-platelet agents: the end of resistance?
Kastrati A
Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents in hemodialysis.
Migliori M; Cantaluppi V; Scatena A; Panichi V
J Nephrol; 2017 Jun; 30(3):373-383. PubMed ID: 27928736
[TBL] [Abstract][Full Text] [Related]
11. Novel Antiplatelet Agents in Cardiovascular Disease.
Tscharre M; Michelson AD; Gremmel T
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):191-200. PubMed ID: 31960728
[TBL] [Abstract][Full Text] [Related]
12. Proteomic signatures of antiplatelet drugs: new approaches to exploring drug effects.
Marcone S; Dervin F; Fitzgerald DJ
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S323-31. PubMed ID: 26149042
[TBL] [Abstract][Full Text] [Related]
13. Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.
Würtz M; Grove EL
Curr Pharm Des; 2012; 18(33):5344-61. PubMed ID: 22724409
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents: current drugs and future trends.
Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
[TBL] [Abstract][Full Text] [Related]
16. Resisting the temptation to oversimplify antiplatelet resistance.
Bhatt DL
JACC Cardiovasc Interv; 2008 Dec; 1(6):660-2. PubMed ID: 19463381
[No Abstract] [Full Text] [Related]
17. Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar.
Cheng JW
Vasc Health Risk Manag; 2016; 12():263-8. PubMed ID: 27366081
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of antiplatelet agents: towards personalized therapy?
Ahmad T; Voora D; Becker RC
Nat Rev Cardiol; 2011 Aug; 8(10):560-71. PubMed ID: 21826075
[TBL] [Abstract][Full Text] [Related]
19. New directions in antiplatelet therapy.
Ferreiro JL; Angiolillo DJ
Circ Cardiovasc Interv; 2012 Jun; 5(3):433-45. PubMed ID: 22715450
[No Abstract] [Full Text] [Related]
20. Antiplatelet therapies for the treatment of cardiovascular disease.
Michelson AD
Nat Rev Drug Discov; 2010 Feb; 9(2):154-69. PubMed ID: 20118963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
